Home Page – Inochicare

CDSCO Approved

Made in India

AIIMS + IIT Delhi

Healing the Non-Healing Wounds

InoHeal™ Pro — the first portable system that automatically alternates Negative Pressure Wound Therapy and Topical Oxygen Therapy in a single, uninterrupted cycle.

11

RCTs in meta-analysis

844

Patients studied

1.51×

Faster healing rate

Patent-Protected

CDSCO ✓

Dual Therapy

NPWT + TOT

CDSCO Approved

ISO 13485:2016

IEC 60601-1

NABL Certified Accuracy

Patent-Protected

Made in India

Clinical Outcomes

Outcomes that change the standard of care

Higher healing rate

1.51×

Risk Ratio 1.51 (95% CI: 1.32–1.72)

Significantly faster wound closure versus standard NPWT alone across 11 RCTs.

Lower infection rate

73%

Risk Ratio 0.27 (95% CI: 0.12–0.57)

Substantially reduced wound infection and related complications in treated patients.

Days to heal

−9.1

Mean difference: −9.1 days

Patients healed nearly 10 days sooner on average — a clinically meaningful reduction.

Meta-analysis of 11 RCTs · 844 patients (2025) · PROSPERO CRD42024618561

The Clinical Challenge

Chronic wounds don't stall by accident.

Non-healing wounds enter a pathological cycle driven by three compounding barriers: biofilm formation, chronic exudate accumulation, and tissue hypoxia. Each reinforces the others.

Biofilm creates a diffusion barrier that resists both systemic antibiotics and topical treatments. Exudate removes growth factors and exposes fragile granulation tissue to proteolytic degradation.

Hypoxia — tissue oxygen tension below 20 mmHg — impairs fibroblast function, collagen synthesis, and the oxygen-dependent killing mechanisms that protect against re-infection. Standard NPWT cannot resolve this alone.

Biofilm

Chronic Exudate

Tissue Hypoxia

25%

of diabetic patients develop a foot ulcer in their lifetime

$50B

annual global cost of chronic wound management

1 in 5

diabetic foot ulcers leads to amputation

25–40%

hospital readmission rate for non-healing wounds

The InoHeal Pro Approach

One device. Two therapies. Zero manual switching.

InoHeal Pro automatically sequences NPWT and TOT in a continuous cycle, delivering combination therapy with no clinician intervention between phases.

NPWT Phase

Barrier Removal

Precisely regulated negative pressure (−40 to −200 mmHg in 5 mmHg increments) removes exudate and reduces biofilm formation conditions. Advanced PID algorithm maintains ±5% accuracy — NABL certified.

TOT Phase

Oxygen Delivery

100% medical-grade oxygen at 10 mBar, achieving wound-surface pO₂ of ~767–770 mmHg — approximately 5× atmospheric oxygen concentration. Directly corrects the hypoxic state that prevents closure.

Automated

Alternation

The device cycles between both therapies without dressing changes or clinician intervention. A pre-configured programme determines cycle timing — no manual switching, no therapy gaps.

Automated therapy cycle — InoHeal Pro

Wound Prep

Baseline

NPWT Active

−125 mmHg

TOT Active

10 mBar O₂

NPWT Active

−125 mmHg

TOT Active

10 mBar O₂

Cycle repeats continuously · Dressing remains in place throughout · No clinician intervention required between phases

Find Your Path

Information tailored to your role

Whether you’re a clinician, administrator, partner, or patient — we’ve built the right entry point for you.

I'm a Clinician

Evidence summaries, clinical protocols, and dosing guidance for surgeons and wound-care nurses.

Explore

I'm a Hospital / Procurement

Device specifications, compliance documentation, total cost of care analysis, and procurement process.

Explore

I'm a Distributor

Territory availability, regulatory dossier support, commercial partnership model, and application process.

Explore

I'm a Patient or Caregiver

Plain-language explanations of the therapy, what to expect, and how to find a treating clinician.

Explore

Indications

Built for the wounds that don't heal.

Most Common

Diabetic Foot Ulcers

Complex neuropathic wounds with compromised healing. 25% lifetime risk in diabetic patients.

Pressure Ulcers

Stage III–IV pressure injuries requiring aggressive wound bed preparation and infection control.

Venous Leg Ulcers

Chronic venous insufficiency wounds with high exudate burden and recurrence rates.

Post-Surgical Wounds

Dehisced or high-risk surgical incisions requiring accelerated granulation and closure support.

Trauma Wounds

High-energy soft tissue injuries, degloving, and complex lacerations with tissue viability concerns.

Refractory

Infected & Exudating Wounds

Biofilm-burdened wounds refractory to standard antibiotic and debridement protocols.

Awards & Partnerships

Rooted in research. Backed by institutions.

TiE Global Winner

2023

MedTech Innovator Asia Pacific

2023

INAE Entrepreneur of the Year

2022

LIF Global — Royal Academy of Engineering UK

2022

BIRAC WINeR

2021

ASME iSHOW

2021

Founding Partners & Funders

AIIMS

All India Institute of Medical Sciences, New Delhi

IIT Delhi

Indian Institute of Technology Delhi

BIRAC

Biotechnology Industry Research Assistance Council

DST

Department of Science & Technology, Govt. of India

MeitY

Ministry of Electronics & Information Technology

SIB

School of International Biodesign

Get in Touch

Talk to our clinical team

Whether you’re evaluating InoHeal Pro for your unit, exploring distributor opportunities, or reviewing the evidence — our clinical specialists are available to assist.

Device demonstration at your facility

Clinical evidence review and Q&A

Regulatory and compliance documentation

Distributor territory enquiries

Book a Free Demo

Full name *

Dr. Priya Sharma

Work email *

you@hospital.org

Organisation *

AIIMS New Delhi

Role *

Select role

Country *

Select country

Book a Demo

No spam. We’ll respond within one business day.

Inochi Care

Medical Devices

Pioneering combination wound therapy through the synergy of NPWT and Topical Oxygen.

C-86 Second Floor, DDA Sheds, Okhla Phase 1, New Delhi 110020

Products

InoHeal Pro

Consumables & Accessories

Technical Specifications

Download Brochure

Request a Quote

Therapies & Evidence

NPWT + TOT Combination

Negative Pressure Therapy

Topical Oxygen Therapy

Clinical Evidence Hub

Published Studies

ROI Calculator

Wound Types

Diabetic Foot Ulcers

Pressure Ulcers

Venous Leg Ulcers

Post-Surgical Wounds

Trauma Wounds

Infected & Exudating Wounds

Company

About Inochi Care

Research & Development

Awards & Recognition

Become a Distributor

Careers

Made in India

CDSCO Approved

Made in India

AIIMS + IIT Delhi

Healing the Non-Healing Wounds

InoHeal™ Pro — the first portable system that automatically alternates Negative Pressure Wound Therapy and Topical Oxygen Therapy in a single, uninterrupted cycle.

11

RCTs in meta-analysis

844

Patients studied

1.51×

Faster healing rate

Patent-Protected

CDSCO ✓

Dual Therapy

NPWT + TOT

CDSCO Approved

ISO 13485:2016

IEC 60601-1

NABL Certified Accuracy

Patent-Protected

Made in India

Clinical Outcomes

Outcomes that change the standard of care

Higher healing rate

1.51×

Risk Ratio 1.51 (95% CI: 1.32–1.72)

Significantly faster wound closure versus standard NPWT alone across 11 RCTs.

Lower infection rate

73%

Risk Ratio 0.27 (95% CI: 0.12–0.57)

Substantially reduced wound infection and related complications in treated patients.

Days to heal

−9.1

Mean difference: −9.1 days

Patients healed nearly 10 days sooner on average — a clinically meaningful reduction.

Meta-analysis of 11 RCTs · 844 patients (2025) · PROSPERO CRD42024618561

The Clinical Challenge

Chronic wounds don't stall by accident.

Non-healing wounds enter a pathological cycle driven by three compounding barriers: biofilm formation, chronic exudate accumulation, and tissue hypoxia. Each reinforces the others.

Biofilm creates a diffusion barrier that resists both systemic antibiotics and topical treatments. Exudate removes growth factors and exposes fragile granulation tissue to proteolytic degradation.

Biofilm

Chronic Exudate

Tissue Hypoxia

25%

of diabetic patients develop a foot ulcer in their lifetime

$50B

annual global cost of chronic wound management

1 in 5

diabetic foot ulcers leads to amputation

25–40%

hospital readmission rate for non-healing wounds

The InoHeal Pro Approach

One device. Two therapies. Zero manual switching.

InoHeal Pro automatically sequences NPWT and TOT in a continuous cycle, delivering combination therapy with no clinician intervention between phases.

NPWT Phase

Barrier Removal

TOT Phase

Oxygen Delivery

Automated

Alternation

The device cycles between both therapies without dressing changes or clinician intervention. A pre-configured programme determines cycle timing — no manual switching, no therapy gaps.

Automated therapy cycle — InoHeal Pro

Wound Prep

Baseline

NPWT Active

−125 mmHg

TOT Active

10 mBar O₂

NPWT Active

−125 mmHg

TOT Active

10 mBar O₂

Cycle repeats continuously · Dressing remains in place throughout · No clinician intervention required between phases

Find Your Path

Information tailored to your role

Whether you’re a clinician, administrator, partner, or patient — we’ve built the right entry point for you.

I'm a Clinician

Evidence summaries, clinical protocols, and dosing guidance for surgeons and wound-care nurses.

Explore

I'm a Hospital / Procurement

Device specifications, compliance documentation, total cost of care analysis, and procurement process.

Explore

I'm a Distributor

Territory availability, regulatory dossier support, commercial partnership model, and application process.

Explore

I'm a Patient or Caregiver

Plain-language explanations of the therapy, what to expect, and how to find a treating clinician.

Explore

Indications

Built for the wounds that don't heal.

Most Common

Diabetic Foot Ulcers

Complex neuropathic wounds with compromised healing. 25% lifetime risk in diabetic patients.

Pressure Ulcers

Stage III–IV pressure injuries requiring aggressive wound bed preparation and infection control.

Venous Leg Ulcers

Chronic venous insufficiency wounds with high exudate burden and recurrence rates.

Post-Surgical Wounds

Dehisced or high-risk surgical incisions requiring accelerated granulation and closure support.

Trauma Wounds

High-energy soft tissue injuries, degloving, and complex lacerations with tissue viability concerns.

Refractory

Infected & Exudating Wounds

Biofilm-burdened wounds refractory to standard antibiotic and debridement protocols.

Awards & Partnerships

Rooted in research. Backed by institutions.

TiE Global Winner

2023

MedTech Innovator Asia Pacific

2023

INAE Entrepreneur of the Year

2022

LIF Global — Royal Academy of Engineering UK

2022

BIRAC WINeR

2021

ASME iSHOW

2021

Founding Partners & Funders

AIIMS

All India Institute of Medical Sciences, New Delhi

IIT Delhi

Indian Institute of Technology Delhi

BIRAC

Biotechnology Industry Research Assistance Council

DST

Department of Science & Technology, Govt. of India

MeitY

Ministry of Electronics & Information Technology

SIB

School of International Biodesign

Get in Touch

Talk to our clinical team

Whether you’re evaluating InoHeal Pro for your unit, exploring distributor opportunities, or reviewing the evidence — our clinical specialists are available to assist.

Device demonstration at your facility

Clinical evidence review and Q&A

Regulatory and compliance documentation

Distributor territory enquiries

Book a Free Demo

Full name *

Dr. Priya Sharma

Work email *

you@hospital.org

Organisation *

AIIMS New Delhi

Role *

Select role

Country *

Select country

Book a Demo

No spam. We’ll respond within one business day.

Inochi Care

Medical Devices

Pioneering combination wound therapy through the synergy of NPWT and Topical Oxygen.

C-86 Second Floor, DDA Sheds, Okhla Phase 1, New Delhi 110020

Products

InoHeal Pro

Consumables & Accessories

Technical Specifications

Download Brochure

Request a Quote

Therapies & Evidence

NPWT + TOT Combination

Negative Pressure Therapy

Topical Oxygen Therapy

Clinical Evidence Hub

Published Studies

ROI Calculator

Wound Types

Diabetic Foot Ulcers

Pressure Ulcers

Venous Leg Ulcers

Post-Surgical Wounds

Trauma Wounds

Infected & Exudating Wounds

Company

About Inochi Care

Research & Development

Awards & Recognition

Become a Distributor

Careers

Made in India